Mus musculus Protein: Ceacam2 | |||||||||
---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||
InnateDB Protein | IDBP-157777.6 | ||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||
Gene Symbol | Ceacam2 | ||||||||
Protein Name | carcinoembryonic antigen-related cell adhesion molecule 2 | ||||||||
Synonyms | AI267129; Bgp2; Ceacam2-L; | ||||||||
Species | Mus musculus | ||||||||
Ensembl Protein | ENSMUSP00000048118 | ||||||||
InnateDB Gene | IDBG-157771 (Ceacam2) | ||||||||
Protein Structure | |||||||||
UniProt Annotation | |||||||||
Function | |||||||||
Subcellular Localization | |||||||||
Disease Associations | |||||||||
Tissue Specificity | |||||||||
Comments | |||||||||
Interactions | |||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
|
||||||||
Gene Ontology | |||||||||
Molecular Function |
|
||||||||
Biological Process |
|
||||||||
Cellular Component |
|
||||||||
Protein Structure and Domains | |||||||||
PDB ID | MGI:1347246 | ||||||||
InterPro |
IPR003598
Immunoglobulin subtype 2 IPR003599 Immunoglobulin subtype IPR007110 Immunoglobulin-like domain IPR013098 Immunoglobulin I-set IPR013106 Immunoglobulin V-set domain IPR013151 Immunoglobulin |
||||||||
PFAM |
PF07679
PF07686 PF00047 |
||||||||
PRINTS | |||||||||
PIRSF | |||||||||
SMART |
SM00408
SM00409 |
||||||||
TIGRFAMs | |||||||||
Post-translational Modifications | |||||||||
Modification | |||||||||
Cross-References | |||||||||
SwissProt | Q925P2 | ||||||||
PhosphoSite | PhosphoSite-Q925P2 | ||||||||
TrEMBL | |||||||||
UniProt Splice Variant | |||||||||
Entrez Gene | 26367 | ||||||||
UniGene | Mm.439731 | ||||||||
RefSeq | NP_001106839 | ||||||||
MGI ID | |||||||||
MGI Symbol | Ceacam2 | ||||||||
OMIM | |||||||||
CCDS | CCDS52153 | ||||||||
HPRD | |||||||||
IMGT | |||||||||
EMBL | AB500065 AB731450 AC162443 AF101164 AF287912 BC024320 X76085 | ||||||||
GenPept | AAC99458 AAH24320 AAK52602 BAI49177 BAM29120 CAA53699 | ||||||||